|
1
|
Ashley PL and MacDonald RJ:
Tissue-specific expression of kallikrein-related genes in the rat.
Biochemistry. 24:4520–4527. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gerald WL, Chao J and Chao L: Sex
dimorphism and hormonal regulation of rat tissue kallikrein mRNA.
Biochim Biophys Acta. 867:16–23. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yao Y, Sheng Z, Li Y, Yan F, Fu C, Li Y,
Ma G, Liu N, Chao J and Chao L: Tissue kallikrein promotes cardiac
neovascularization by enhancing endothelial progenitor cell
functional capacity. Hum Gene Ther. 23:859–870. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yin H, Chao L and Chao J: Nitric oxide
mediates cardiac protection of tissue kallikrein by reducing
inflammation and ventricular remodeling after myocardial
ishchemia/reperfusion. Life Sci. 82:156–165. 2008. View Article : Google Scholar
|
|
5
|
Liu Y, Bledsoe G, Hagiwara M, Yang ZR,
Shen B, Chao L and Chao J: Blockade of endogenous tissue kallikrein
aggravates renal injury by enhancing oxidative stress and
inhibiting matrix degradation. Am J Physiol Renal Physiol.
298:F1033–F1040. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lan W, Yang F, Liu L, Yin Q, Li M, Li Z,
Sang H, Xu G, Ma M, Zhang Z, et al: Tissue kallikrein preventing
the restenosis after stenting of symptomatic MCA atherosclerotic
stenosis (KPRASS). Int J Stroke. 9:533–535. 2014. View Article : Google Scholar
|
|
7
|
Yu HZ, Xie LD, Zhu PL, Xu CS and Wang HJ:
Human tissue kallikrein 1 gene delivery inhibits PDGF-BB-induced
vascular smooth muscle cells proliferationand upregulates the
expressions of p27Kip1 and p2lCip1. Mol Cell Biochem. 360:363–371.
2012. View Article : Google Scholar
|
|
8
|
Yu HZ, Xie LD, Zhu PL, Xu CS, Wang HJ and
Li TY: Effects of human tissue kallikrein 1 gene delivery on
carotid artery neointima formation after balloon angioplasty in
spontaneously hypertensive rats. Zhonghua Xin Xue Guan Bing Za Zhi.
38:67–71. 2010.In Chinese. PubMed/NCBI
|
|
9
|
Heagerty AM, Heerkens EH and Izzard AS:
Small artery structure and function in hypertension. J Cell Mol
Med. 14:1037–1043. 2010.PubMed/NCBI
|
|
10
|
Intengan HD and Schiffrin EL: Vascular
remodeling in hypertension: Roles of apoptosis, inflammation and
fibrosis. Hypertension. 38:581–587. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zitka O, Kukacka J, Krizkova S, Huska D,
Adam V, Masarik M, Prusa R and Kizek R: Matrix metalloproteinases.
Curr Med Chem. 17:3751–3768. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Papazafiropoulou A and Tentolouris N:
Matrix metalloproteinases and cardiovascular diseases. Hippokratia.
13:76–82. 2009.PubMed/NCBI
|
|
13
|
Docherty AJ, Lyons A, Smith BJ, Wright EM,
Stephens PE, Harris TJ, Murphy G and Reynolds JJ: Sequence of human
tissue inhibitor of metalloproteinases and its identity to
erythroid-potentiating activity. Nature. 318:66–69. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dollery CM, Humphries ES, McClelland A,
Latchman DS and McEwan JR: Expression of tissue inhibitor of matrix
metal-loproteinases 1 by use of an adenoviral vector inhibits
smooth muscle cell migration and reduces neointimal hyperplasia in
the rat model of vascular balloon injury. Circulation.
99:3199–3205. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pei Z, Chu L, Zou W, Zhang Z, Qiu S, Qi R,
Gu J, Qian C and Liu X: An oncolytic adenoviral vector of Smac
increases antitumor activity of TRAIL against HCC in human cells
and in mice. Hepatology. 39:1371–1381. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen Y, Muramatsu SI, Ikeguchi K, Fujimoto
KI, Fan DS, Ogawa M, Mizukami H, Urabe M, Kume A, Nagatsu I, et al:
Triple transduction with adeno-associated virus vectors expressing
tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase and GTP
cyclohydrolase I for gene therapy of Parkinson's disease. Hum Gene
Ther. 11:1509–1519. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ngoi SM, Chien AC and Lee CG: Exploiting
internal ribosome entry sites in gene therapy vector design. Curr
Gene Ther. 4:15–31. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Denes L, Entz L and Jancsik V: Restenosis
and therapy. Int J Vasc Med. 4062362012.PubMed/NCBI
|
|
19
|
Ng P, Parks RJ, Cummings DT, Evelegh CM,
Sankar U and Graham FL: A high-efficiency Cre/loxP-based system for
construction of adenoviral vectors. Hum Gene Ther. 10:2667–2672.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maeda M, Namikawa K, Kobayashi I, Ohba N,
Takahara Y, Kadono C, Tanaka A and Kiyama H: Targeted gene therapy
toward astrocytoma using a Cre/loxP-based adenovirus system. Brain
Res. 1081:34–43. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen HF, Xie LD and Xu CS: The signal
transduction pathways of heat shock protein 27 phosphorylation in
vascular smooth muscle cells. Mol Cell Biochem. 333:49–56. 2010.
View Article : Google Scholar
|
|
22
|
Gariepy J, Massonneau M, Levenson J,
Heudes D and Simon A: Evidence for in vivo carotid and femoral wall
thickening in human hypertension. Groupe de Prévention
Cardio-vasculaire en Médecine du Travail. Hypertension. 22:111–118.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wilson DR: Viral-mediated gene transfer
for cancer treatment. Curr Pharm Biotechnol. 3:151–164. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eefting D, Seghers L, Grimbergen JM, de
Vries MR, de Boer HC, Lardenoye JW, Jukema JW, van Bockel JH and
Quax PH: A novel urokinase receptor-targeted inhibitor for plasmin
and matrix metalloproteinases suppresses vein graft disease.
Cardiovasc Res. 88:367–375. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang M, Shi W, Zhang Q, Wang X, Guo M,
Cui Z, Su C, Yang Q, Li Y, Sham J, et al: Gene therapy using
adenovirus-mediated full-length anti-HER-2 antibody for HER-2
overexpression cancers. Clin Cancer Res. 12:6179–6185. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo SY, Shen X, Yang J, Yuan J, Yang RL,
Mao K, Zhao DH and Li CJ: TIMP-1 mediates the inhibitory effect of
interleukin-6 on the proliferation of a hepatocarcinoma cell line
in a STAT3-dependent manner. Braz J Med Biol Res. 40:621–631. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao YD, Li ZY, Sheng WH, Miao J and Yang
J: Adenovirus-mediated ING4/IL-24 double tumor suppressor gene
co-transfer enhances antitumor activity in human breast cancer
cells. Oncol Rep. 28:1315–1324. 2012.PubMed/NCBI
|
|
28
|
Deng WG, Kawashima H, Wu G, Jayachandran
G, Xu K, Minna JD, Roth JA and Ji L: Synergistic tumor suppression
by coexpression of FUS1 and p53 is associated with down-regulation
of murine double minute-2 and activation of the apoptotic
protease-activating factor 1-dependent apoptotic pathway in human
non-small cell lung cancer cells. Cancer Res. 67:709–717. 2007.
View Article : Google Scholar : PubMed/NCBI
|
